Facebook Twitter Youtube Instagram Telegram Whatsapp

Anvisa aprova o segundo genérico de semaglutida do país em uma semana

SÃO PAULO, SP (FOLHAPRESS) – A Anvisa (Agência Nacional de Vigilância Sanitária) aprovou o segundo medicamento genérico de semaglutida do país. O r…
leia mais no Notícias ao Minuto Brasil aqui.

Gostou deste conteúdo? Compartilhe...

Facebook
Twitter
Email
Twitter
WhatsApp
LinkedIn

Patrocinador:

Ultimas Notícias

TODOS OS DIREITOS RESERVADOS

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by